Assembly Biosciences (ASMB) Competitors

Assembly Biosciences (NASDAQ:ASMB) and Omeros (NASDAQ:OMER) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Is ASMB or OMER more profitable?

Omeros has a net margin of 0.00% compared to Assembly Biosciences' net margin of -144.05%. Omeros' return on equity of 0.00% beat Assembly Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Assembly Biosciences	-144.05%	-121.46%	-34.56%
Omeros	N/A	N/A	-49.92%

Do analysts rate ASMB or OMER?

Assembly Biosciences currently has a consensus price target of $33.00, suggesting a potential upside of 127.51%. Omeros has a consensus price target of $22.50, suggesting a potential upside of 601.81%. Given Omeros' stronger consensus rating and higher probable upside, analysts clearly believe Omeros is more favorable than Assembly Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assembly Biosciences	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Omeros	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Does the media prefer ASMB or OMER?

In the previous week, Omeros had 18 more articles in the media than Assembly Biosciences. MarketBeat recorded 18 mentions for Omeros and 0 mentions for Assembly Biosciences. Assembly Biosciences' average media sentiment score of 0.00 beat Omeros' score of -0.10 indicating that Assembly Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Assembly Biosciences	Neutral
Omeros	Neutral

Which has more risk and volatility, ASMB or OMER?

Assembly Biosciences has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, Omeros has a beta of 2.42, suggesting that its stock price is 142% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in ASMB or OMER?

19.9% of Assembly Biosciences shares are held by institutional investors. Comparatively, 48.8% of Omeros shares are held by institutional investors. 5.1% of Assembly Biosciences shares are held by company insiders. Comparatively, 12.3% of Omeros shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community favor ASMB or OMER?

Omeros received 507 more outperform votes than Assembly Biosciences when rated by MarketBeat users. Likewise, 70.65% of users gave Omeros an outperform vote while only 58.65% of users gave Assembly Biosciences an outperform vote.

Company	Underperform	Outperform
Assembly Biosciences	Outperform Votes 244 58.65%	Underperform Votes 172 41.35%
Omeros	Outperform Votes 751 70.65%	Underperform Votes 312 29.35%

Which has better earnings and valuation, ASMB or OMER?

Assembly Biosciences has higher revenue and earnings than Omeros. Assembly Biosciences is trading at a lower price-to-earnings ratio than Omeros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assembly Biosciences	$32.15M	3.45	-$61.23M	-$6.23	-2.33
Omeros	N/A	N/A	-$117.81M	-$2.65	-1.21

Summary

Omeros beats Assembly Biosciences on 13 of the 17 factors compared between the two stocks.